Yongin-si, South Korea

Myunggyu Park

USPTO Granted Patents = 3 



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2011)
  • Yongin-si, KR (2013 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Myunggyu Park: A Focus on Health

Introduction

Myunggyu Park, an accomplished inventor based in Yongin-si, South Korea, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Park has dedicated his research to addressing serious health issues such as obesity, diabetes, and neuro-degenerative diseases through innovative pharmaceutical compositions.

Latest Patents

Park's most recent patents focus on pharmaceutical compositions designed for the treatment and prevention of diseases linked to obesity, diabetes, metabolic syndrome, neuro-degenerative conditions, and mitochondrial dysfunction. These compositions provide a therapeutically effective amount of specific compounds, which are crucial for combating these diseases. The innovative formulations include pharmaceutically acceptable salts, prodrugs, solvates, or isomers, blended with suitable carriers, diluents, or excipients. This approach showcases Park’s commitment to developing effective treatments for complex health challenges.

Career Highlights

Throughout his career, Myunggyu Park has collaborated with prominent companies, including Md Bioalpha Co., Ltd. and KT&G Corporation. His work in these organizations has contributed to the development of cutting-edge pharmaceutical solutions.

Collaborations

In his professional journey, Park has worked alongside talented individuals like Taehwan Kwak and Sang-Ku Yoo. These collaborations have enhanced his research and allowed for the combination of diverse expertise in the field of pharmaceutical innovation.

Conclusion

Myunggyu Park stands out as a significant figure in the pharmaceutical industry, particularly in developing novel treatments for conditions linked to metabolic dysfunctions. His contributions not only highlight the importance of innovation in healthcare but also inspire future researchers and inventors to pursue advancements that can improve global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…